Invest in us
Backing the future of assisted reproduction
We are building the connected platform for embryology — trusted by clinics in 45 countries, grounded in peer-reviewed science, and designed to become the standard of the modern IVF lab.
Traction
Trusted by clinics worldwide
45
Countries
173
Clinics connected
9,800+
Procedures supported
20+
Peer-reviewed publications
Market
A large, growing opportunity
~3M
IVF cycles per year, globally
~8,500
IVF clinics worldwide
$1.8B
IVF software market by 2030 (CAGR ~12%)
~45,000
Embryologists worldwide
Market figures from industry sources (ESHRE, CDC, market research); indicative.
Why us
The investment thesis
A full-stack ecosystem
We cover every cell — sperm, oocyte, embryo — under one platform, instead of a single point tool.
A defensible data moat
Connected, media-rich, outcome-linked data across products is uniquely hard to replicate.
Global, underpenetrated market
Connected software adoption in IVF is still early across most regions — a large runway for growth.
Product-led distribution
A professional community and integrated products turn everyday lab work into organic reach and adoption.
Founding team
Decades of embryology. A new kind of company.
IVF 2.0 was founded by pioneers whose work helped shape modern assisted reproduction.
Alejandro Chávez-Badiola
MD
Founding Partner & CEO
Reproductive medicine specialist and AI pioneer. Founded IVF 2.0 in 2018; co-author of the foundational ERICA and SiD studies published in Nature and RBMO.
Jacques Cohen
HCLD, M.Sc., PhD
Founding Partner & Chief Embryology Director
One of the field’s most influential embryologists — trained with IVF pioneers Steptoe and Edwards; achieved the first successful human blastocyst freeze-thaw. 300+ publications, 12 patents.
Andrew J. Drakeley
MD (MB ChB), M.Sc., MRCOG
Founding Partner & COO
Consultant gynaecologist and Clinical Director of the Hewitt Fertility Centre (NHS). Brings the perspective of an actively practising sub-specialist to the ecosystem.